Filter
607
Text search:
pharmaceutical
regulatory
authority
Featured
Recommendations
52
New Publications
198
Language
Document type
No document type
335
Studies & Reports
104
Guidelines
88
Manuals
34
Strategic & Response Plan
26
Fact sheets
8
Situation Updates
5
Training Material
4
Resource Platforms
2
Brochures
1
Countries / Regions
Kenya
36
Ethiopia
31
India
25
Uganda
24
South Africa
20
Ghana
17
Tanzania
17
Liberia
16
Rwanda
16
Nigeria
15
Zambia
15
Malawi
13
Nepal
11
Sierra Leone
10
Zimbabwe
10
Western and Central Europe
10
Bangladesh
9
Namibia
8
Ukraine
8
Myanmar / Burma
8
Lesotho
7
Global
7
Eastern Europe
6
Philippines
5
Indonesia
5
Eswatini/ Swaziland
5
Botswana
5
Syria
4
Cambodia
4
Benin
3
Albania
3
Guinea
2
Senegal
2
Congo, Democratic Republic of
2
Cameroon
2
Haiti
2
Pakistan
2
Jordan
2
Thailand
2
West and Central Africa
2
Middle East and North Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
Africa
2
Laos
2
USA
1
Somalia
1
Afghanistan
1
Germany
1
Chad
1
Mozambique
1
Papua New Guinea
1
Sudan
1
North Macedonia
1
East and Southern Africa
1
Western Pacific Region
1
Latin America and the Carribbean
1
Fiji
1
Timor Leste/ East Timor
1
Moldova
1
Australia
1
Vietnam
1
Gabon
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
325
Clinical Guidelines
33
Pharmacy & Technologies
19
Key Resources
17
Public Health
9
Women & Child Health
8
Capacity Building
3
Toolboxes
Pharmacy
88
AMR
81
COVID-19
30
TB
23
Rapid Response
22
HIV
19
Mental Health
17
Global Health Education
9
Ebola
6
Conflict
6
Planetary Health
6
Health Financing Toolbox
5
NCDs
4
Specific Hazards
3
Caregiver
3
NTDs
3
Polio
2
Refugee
2
Natural Hazards
1
Zika
1
This curricula guide builds on several existing products of WHO and partners, aimed at supporting countries in their effort to address the first objective of the GAP-AMR (to improve awareness and understanding of AMR). It is targeted specifically at health educators and policy planners, and applies
...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covi
...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2
...
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of medicines for acute and chronic conditions as well as opinions and perceptio
...
Drug Advisory Board
Annex 5, WHO Technical Report Series 1010, 2018
Therapeutics Information and Pharmacovigilance Centre | TIPC
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
First edition, November 1997 | Revised July 2002
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Guidelines for Medicine Donations
recommended
This 3rd edition of Guidelines for medicine donations has been developed by the World Health Organization (WHO) in cooperation with major international agencies active in humanitarian relief and development assistance. The guidelines are intended to improve the quality of medicine donations in inter
...
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there
...
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Access to controlled medicines. 3rd edition